In addition, a higher protein level of MARCKSL1 was positively correlated with lymph node metastasis, and ESCC patients with high expression levels of MARCKSL1 had a worse survival rate, thereby providing an applicable prognosticator and a potential therapeutic target for ESCC patients. The gene discussed is MARCKSL1; the disease is esophageal squamous cell carcinoma.